Tag:
Active Biotech
Latest Headlines
Latest Headlines
Active Biotech gets boost from late-stage oral MS program
Active Biotech's ( $ACTI ) shares jumped after its partner Teva Pharmaceutical ( $TEVA ) touted results of a late-stage trial for an oral multiple sclerosis drug under development with Active. While...
Teva's laquinimod for MS gets fast tracked
Israel-based Teva Pharmaceutical announced today that the FDA has granted the Fast Track designation to laquinimod, its investigational treatment for relapsing-remitting multiple sclerosis (RRMS).
